معرفی
Prof. Karen Bieback is a Professor at the Medical Faculty Mannheim, Heidelberg University, leading the Experimental Cell Therapy group within the Transfusion Medicine and Immunology department. Her research focuses on regenerative medicine, particularly mesenchymal stromal cells (MSCs) and endothelial precursor cells. She co-leads the RenalToolBox EU project, addressing kidney diseases through cell-based therapies. Her work integrates cell biology, immunology, and bioengineering, with a focus on clinical translation and GMP-compliant manufacturing.
Education details are not explicitly stated, but her academic role implies advanced degrees in biomedical sciences. Her research spans immunomodulatory mechanisms of MSCs, kidney injury treatment, and diabetic retinopathy therapies. She manages FlowCore, a flow cytometry core facility, and collaborates on EU-funded networks like RenalToolBox and DIAMICOM. Key grants include DFG funding for red blood cell storage studies and Marie Skłodowska-Curie Actions.
Research interests emphasize stem cell therapies, extracellular vesicles, and 3D organ models to reduce animal testing. Recent work includes optimizing MSC-based treatments for diabetic wound healing and kidney injuries. Her team studies red blood cell storage lesions and plasticizer effects. She supervises doctoral candidates like Eleonora Scaccia and Erika Erika in EU projects.
Labs/groups include the AG Bieback within MI3 (Mannheim Institute for Innate Immunoscience), focusing on vascular biology and innate immunity. Her work bridges basic research with clinical applications, aiming to translate cell therapies into medical practice.
